智慧芽：2022儿科疾病治疗分析与药物研究报告（33页）.pdf

1、?https:/?https:/?02?03?01?04?05Contents?https:/?900?2016?研?务?群?群?39.2%39.2%?20.5%20.5%?17.6%17.6%?15.8%15.8%?务?2019?研?2019?0 0-1515?2497724977?17.8%17.8%?16-59?89640?64.0%?60?副?25388?18.1%?务?65?副?17603?12.6%?17.80%64%18.10%2019?0-15?16-59?60?务?务?300-400?2024?2.69?(?研)?溶?3?/?9%?研?研?60%60%?研?5%5%?17.8

2、%17.8%?2011?2011?384?384?副?副?2019?2019?872?872?10.80%10.80%?务?10.69%?39.20%20.50%17.60%15.80%?6.81%?https:/?研?1?2?研务?务?90%90%?54.46%41.44%4.10%?1 1?6.3%12.9%24.4%0.0%5.0%10.0%15.0%20.0%25.0%30.0%?1 10.1%0.1%研NMPA?研?6000?10?0.1%?0 0-1 1?1 1-2424?3 3-5 5?6 6-1414?1.84?930?5%?群?90%?1?https:/?研?研?研?研?研?

3、导?试?试?试?6000?10?告?90%?副?75%?副?3 3500500+?60+60+?诱?https:/?模?模?务?;?务?告?模?模?4?的?研?https:/?CFDA?够?11?20032003201620162013201320112011?(CFDA)?(?3尼)?20042004?务?(2011?2020?)?的?务?20122012CFDA?够?研?研?吐?20152015?溶?告?资?告?确?2021202120222022?务?,?12?https:/?模?务?(?ICH)?ICH?E11/S11?/M11?2014?务?够?务?2016?研?研?务?研?研?研?

4、研?研?2017?溶?务?研?务?CDE?https:/?FDA?模?1979?FDA?1994?1997?FDA?务?6?2002?&2003?吐?PBCA?PREA?2?2007?FDA?2007?吐?2012?FDA?II?够?够?研?2019?FDA?2-12?12-17?FDA?够?务?62%85%?2005?2015?600600?务?2810531522699?BPCA?PREA?BPCA?PREA2007-2020?2007-2012?2012-2020?00001747352002040602012 2013 2014 2015 2016 2017 2018 20192012

5、-2019?(?)?1979?务?2003?https:/?%?4?71116.76?4?63516.49?-?3?86813.76?2?97710.59?2?7289.70?1?1163.97?1?0563.76?E?1?0083.59?9273.30?9243.29?23?95085.19-?%?220?89048.92?副?群100?14522.18?38?2738.48?18?1174.01?9?6342.13?7?6161.69?7?0571.56?5?9801.32?5?6921.26?-?4?7201.05?418?12492.61-?1.?10?2.?10?务?务?0 0 18

6、18?20102010 20162016?务?务?https:/?研?95%?%?186?96273.11?54?60621.35?4?4831.75?4?3661.71?1?7980.70?1?0740.42?8470.33?6050.24?4420.17?2790.11?255?46299.90?%?副?群113?08146.09?31?95913.02?22?4269.14?22?2049.05?14?6535.97?13?9185.67?9?2083.75?4?4831.83?3?8871.58?3?0171.23?238?83697.34-?3.?10?4.?10?https:/?/